Baxter explores potential sale of Kidney Care business to private equity; spinoff still possible

BAXTER INTERNATIONAL INC

Baxter discloses discussions with select private equity investors regarding a potential sale of its Kidney Care business.
No final decision on separation structure; spinoff remains an option and progress continues.
Baxter reaffirms commitment to separate Kidney Care business in the second half of 2024.
The update is provided as Regulation FD disclosure; forward-looking statements caution.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.